Researchers have shown that in cancer vaccines, how the ingredients are arranged can be just as important as what they are made of. A new study demonstrates structural nanomedicine, a field focused on nanoscale vaccine design.
Scientists discovered that simply changing how a cancer-targeting peptide is positioned on a nanoparticle can greatly strengthen the immune response. In HPV-positive cancers, vaccines that displayed the antigen through its N-terminus produced up to eight times more interferon-gamma, a key anti-tumor immune signal, compared to other designs. This optimized structure slowed tumor growth, extended survival in animal studies, and doubled to tripled cancer-cell killing in human patient samples.
Instead of the traditional “mix-and-match” method of combining vaccine ingredients, the researchers used carefully engineered structures known as Spherical Nucleic Acids (SNAs). This bottom-up design improves how immune cells recognize and process the vaccine, leading to stronger effects with potentially lower toxicity. The findings suggest that some past vaccine failures may have been due to poor structural design rather than ineffective ingredients. In the future, artificial intelligence may help scientists quickly test thousands of structural combinations to identify the most powerful cancer vaccine designs.